CLYM
Climb Bio
CLYM
CLYM
76 hedge funds and large institutions have $63.4M invested in Climb Bio in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less capital invested
Capital invested by funds: $100M → $63.4M (-$36.9M)
Holders
76
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.23M | |
| 2 | +$1.65M | |
| 3 | +$1.22M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.22M |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$676K |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$4.7M | |
| 3 | -$3M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$1.37M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.22M |
